HighTower Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,971
| Closed | -$315K | – | 3590 |
|
|
2025
Q1 | $315K | Buy |
20,971
+7,618
| +57% | +$114K | ﹤0.01% | 2809 |
|
|
2024
Q4 | $220K | Sell |
13,353
-2,530
| -16% | -$41.6K | ﹤0.01% | 3100 |
|
|
2024
Q3 | $387K | Buy |
15,883
+1,615
| +11% | +$39.4K | ﹤0.01% | 2610 |
|
|
2024
Q2 | $361K | Buy |
14,268
+292
| +2% | +$7.39K | ﹤0.01% | 2560 |
|
|
2024
Q1 | $356K | Buy |
13,976
+3,534
| +34% | +$90K | ﹤0.01% | 2537 |
|
|
2023
Q4 | $239K | Buy |
+10,442
| New | +$239K | ﹤0.01% | 2865 |
|
|
2021
Q1 | – | Sell |
-9,462
| Closed | -$425K | – | 2838 |
|
|
2020
Q4 | $425K | Buy |
9,462
+617
| +7% | +$27.7K | ﹤0.01% | 1690 |
|
|
2020
Q3 | $314K | Buy |
8,845
+991
| +13% | +$35.2K | ﹤0.01% | 1792 |
|
|
2020
Q2 | $298K | Buy |
7,854
+1,035
| +15% | +$39.3K | ﹤0.01% | 1724 |
|
|
2020
Q1 | $200K | Buy |
+6,819
| New | +$200K | ﹤0.01% | 1770 |
|
|
2019
Q4 | – | Sell |
-4,204
| Closed | -$230K | – | 2184 |
|
|
2019
Q3 | $230K | Buy |
+4,204
| New | +$230K | ﹤0.01% | 1966 |
|